Clinical Trial Update: Bioequivalence Study of Cephalexin Tablets 1g [Phase 1]

View source ↗

Summary

A Phase 1 bioequivalence study of Cephalexin 1 g tablets was completed. The trial assessed pharmacokinetic bioequivalence in healthy volunteers.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Respiratory Tract Infections

Drugs mentioned

• Cephalexin (Cephalexin)

Snippet

Sponsor: GlaxoSmithKline | Conditions: Infections, Respiratory Tract | Phase 1 | Status: COMPLETED